Studies on the in vitro assembly of a beta 1-40: implications for the search for a beta fibril formation inhibitors.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of Structural Biology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 10940227
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Assembly of A beta amyloid protofibrils: an in vitro model for a possible early event in Alzheimer's disease.

  1999cited by this paper
• Quantifying amyloid beta-peptide (Abeta) aggregation using the Congo red-Abeta (CR-abeta) spectrophotometric assay.

  1999cited by this paper
• Watching amyloid fibrils grow by time-lapse atomic force microscopy.

  1999cited by this paper
• Recognition sequence design for peptidyl modulators of beta-amyloid aggregation and toxicity.

  1999cited by this paper
• Translating cell biology into therapeutic advances in Alzheimer's disease

  1999cited by this paper
• Morphological development of beta(1-40) amyloid fibrils.

  1999cited by this paper
• An Ultrastructural Study of Amyloid Intermediates in Aβ1–42 Fibrillogenesis

  1999cited by this paper
• Protofibrillar Intermediates of Amyloid β-Protein Induce Acute Electrophysiological Changes and Progressive Neurotoxicity in Cortical Neurons

  1999cited by this paper
• Modified-peptide inhibitors of amyloid beta-peptide polymerization.

  1999cited by this paper
• Amyloid diseases: abnormal protein aggregation in neurodegeneration.

  1999cited by this paper
• An atomic model for the pleated beta-sheet structure of Abeta amyloid protofilaments.

  1999cited by this paper
• Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates.

  1999cited by this paper
• A Molecular Model of Alzheimer Amyloid β-Peptide Fibril Formation*

  1999cited by this paper
• Complement-dependent Proinflammatory Properties of the Alzheimer's Disease β-Peptide

  1998cited by this paper
• Microglia, scavenger receptors, and the pathogenesis of Alzheimer's disease.

  1998cited by this paper
• Detection of single amyloid β-protein aggregates in the cerebrospinal fluid of Alzheimer's patients by fluorescence correlation spectroscopy

  1998cited by this paper
• Rapid assembly of Alzheimer-like paired helical filaments from microtubule-associated protein tau monitored by fluorescence in solution.

  1998cited by this paper
• Structural analysis of Alzheimer's beta(1-40) amyloid: protofilament assembly of tubular fibrils.

  1998cited by this paper
• Molecular modeling of the Abeta1-42 peptide from Alzheimer's disease.

  1998cited by this paper
• Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity.

  1998cited by this paper
• Solution structure of methionine-oxidized amyloid beta-peptide (1-40). Does oxidation affect conformational switching?

  1998cited by this paper
• Amyloid fibrils may be assembled from beta-helical protofibrils.

  1998cited by this paper
• Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.

  1998cited by this paper
• Oligomerization of endogenous and synthetic amyloid beta-protein at nanomolar levels in cell culture and stabilization of monomer by Congo red.

  1998cited by this paper
• The importance of inflammatory mechanisms in Alzheimer disease.

  1998cited by this paper
• Polymorphic fibrillar assembly of human amylin.

  1997cited by this paper
• Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins.

  1997cited by this paper
• Observation of metastable Abeta amyloid protofibrils by atomic force microscopy.

  1997cited by this paper
• Stopped-flow kinetics reveal multiple phases of thioflavin T binding to Alzheimer beta (1-40) amyloid fibrils.

  1997cited by this paper
• Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-beta protein.

  1997cited by this paper
• Kinetic theory of fibrillogenesis of amyloid beta-protein.

  1997cited by this paper
• Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate.

  1997cited by this paper
• The molecular basis of amyloidosis

  1997cited by this paper
• A beta deposition inhibitor screen using synthetic amyloid.

  1997cited by this paper
• Selective Inhibition of A Fibril Formation

  1996cited by this paper
• The nanometer-scale structure of amyloid-beta visualized by atomic force microscopy.

  1996cited by this paper
• On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants.

  1996cited by this paper
• Mechanisms of neuronal degeneration in Alzheimer's disease.

  1996cited by this paper
• Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease.

  1996cited by this paper
• Morphology and Toxicity of Aβ-(1-42) Dimer Derived from Neuritic and Vascular Amyloid Deposits of Alzheimer's Disease*

  1996cited by this paper
• Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains.

  1996cited by this paper
• The toxicity in vitro of beta-amyloid protein.

  1995cited by this paper
• Aggregation of Secreted Amyloid -Protein into Sodium Dodecyl Sulfate-stable Oligomers in Cell Culture (*)

  1995cited by this paper
• The -Helical to -Strand Transition in the Amino-terminal Fragment of the Amyloid -Peptide Modulates Amyloid Formation *

  1995cited by this paper
• Solvent effects on self-assembly of beta-amyloid peptide.

  1995cited by this paper
• Examination of the structure of the transthyretin amyloid fibril by image reconstruction from electron micrographs.

  1995cited by this paper
• Architecture and polymorphism of fibrillar supramolecular assemblies produced by in vitro aggregation of human calcitonin.

  1995cited by this paper
• Racemization of Asp23 residue affects the aggregation properties of Alzheimer amyloid beta protein analogues.

  1994cited by this paper
• Effect of acid predissolution on fibril size and fibril flexibility of synthetic beta-amyloid peptide.

  1994cited by this paper
• Application of scanning transmission electron microscopy to the study of biological structure.

  1993cited by this paper
• Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?

  1993cited by this paper
• Thioflavine T interaction with synthetic Alzheimer's disease β‐amyloid peptides: Detection of amyloid aggregation in solution

  1993cited by this paper
• In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity.

  1991cited by this paper
• Aggregation-related toxicity of synthetic beta-amyloid protein in hippocampal cultures.

  1991cited by this paper
• Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease.

  1989cited by this paper
• Polymorphism of reconstituted human epidermal keratin filaments: determination of their mass-per-length and width by scanning transmission electron microscopy (STEM).

  1985cited by this paper
• X-RAY DIFFRACTION STUDIES ON AMYLOID FILAMENTS

  1968cited by this paper
• HIGH-RESOLUTION ELECTRON MICROSCOPIC ANALYSIS OF THE AMYLOID FIBRIL

  1967cited by this paper

• Insights into proton transfer dynamics in histidine tautomers of amyloid-β (1-40)

  2025cites this paper
• Hydrophobic C-Terminal Peptide Analog Aβ31-41 Protects the Neurons from Aβ-Induced Toxicity.

  2024cites this paper
• Exploring the complexity of amyloid-beta fibrils: structural polymorphisms and molecular interactions.

  2024cites this paper
• Principles and Biomedical Applications of Self-Assembled Peptides: Potential Treatment of Type 2 Diabetes Mellitus

  2024cites this paper
• An N-terminal acidic β-sheet domain is responsible for the metal-accumulation properties of amyloid-β protofibrils: a molecular dynamics study

  2024cites this paper
• Controlling Amyloid Beta Peptide Aggregation and Toxicity by Protease-Stable Ligands

  2023cites this paper
• Early events in amyloid-β self-assembly probed by time-resolved solid state NMR and light scattering

  2023cites this paper
• How Single Site Mutations Can Help Understanding Structure Formation of Amyloid β1-40.

  2023cites this paper
• Deciphering the prion-like behavior of pathogenic protein aggregates in neurodegenerative diseases.

  2022cites this paper
• Sensing Cells-Peptide Hydrogel Interaction In Situ via Scanning Ion Conductance Microscopy

  2022cites this paper
• The Cryo-EM Effect: Structural Biology of Neurodegenerative Disease Aggregates.

  2021cites this paper
• Constraints on the Structure of Fibrils Formed by a Racemic Mixture of Amyloid-β Peptides from Solid-State NMR, Electron Microscopy, and Theory.

  2021cites this paper
• Aggregation and structure of amyloid β-protein.

  2021cites this paper
• Small-Molecule Targeted Aβ42 Aggregate Degradation: Negatively Charged Small Molecules Are More Promising than the Neutral Ones.

  2021cites this paper
• Bushen-Tiansui Formula Improves Cognitive Functions in an Aβ1–42 Fibril-Infused Rat Model of Alzheimer's Disease

  2020cites this paper
• Dual Effect of the Acidic Polysaccharose Ulvan on the Inhibition of Aβ Fibrillation and Disintegration of Mature Fibrils.

  2020cites this paper
• How Does the Mono-Triazole Derivative Modulate Aβ42 Aggregation and Disrupt a Protofibril Structure: Insights from Molecular Dynamics Simulations

  2020cites this paper
• Interactions of a multifunctional di-triazole derivative with Alzheimer's Aβ42 monomer and Aβ42 protofibril: a systematic molecular dynamics study.

  2019cites this paper
• Tautomerization Effect of Histidines on Oligomer Aggregation of β-Amyloid(1-40/42) during the Early Stage: Tautomerism Hypothesis for Misfolding Protein Aggregation.

  2019cites this paper
• Multivalent Polymer-Peptide Conjugates-A General Platform for Inhibiting Amyloid Beta Peptide Aggregation.

  2019cites this paper
• New Mechanism of Amyloid Fibril Formation.

  2019cites this paper
• Exploration of insulin amyloid polymorphism using Raman spectroscopy and imaging

  2019cites this paper
• Acetylation of Aβ40 alters aggregation in the presence and absence of lipid membranes.

  2019cites this paper
• Cryo-EM structure and polymorphism of Aβ amyloid fibrils purified from Alzheimer’s brain tissue

  2019cites this paper
• Structural and Binding Properties on Aβ Mature Fibrils Due to the Histidine Tautomeric Effect.

  2019cites this paper
• To Be Fibrils or To Be Nanofilms? Oligomers Are Building Blocks for Fibril and Nanofilm Formation of Fragments of Aβ Peptide.

  2018cites this paper
• Congo Red and amyloids: history and relationship

  2018cites this paper
• Studies of the Process of Amyloid Formation by Aβ Peptide

  2018cites this paper
• Comparing the Folds of Prions and Other Pathogenic Amyloids

  2018cites this paper
• Fibrillization of β-Amyloid Peptides via Chemically Modulated Pathway.

  2018cites this paper
• Amyloid fibril polymorphism: a challenge for molecular imaging and therapy

  2018cites this paper
• Amyloid beta: structure, biology and structure-based therapeutic development

  2017cites this paper
• Strategy to discover full-length amyloid-beta peptide ligands using high-efficiency microarray technology

  2017cites this paper
• The Levinthal Problem in Amyloid Aggregation: Sampling of a Flat Reaction Space.

  2017cites this paper
• Rosetta Stone for Amyloid Fibrils: The Key Role of Ring-Like Oligomers in Amyloidogenesis

  2017cites this paper
• Covalent modifications of the amyloid beta peptide by hydroxynonenal: Effects on metal ion binding by monomers and insights into the fibril topology.

  2017cites this paper
• ThT 101: a primer on the use of thioflavin T to investigate amyloid formation

  2017cites this paper
• How Does the P7C3-Series of Neuroprotective Small Molecules Prevent Membrane Disruption?

  2017cites this paper
• Flexibility and Solvation of Amyloid-β Hydrophobic Core*

  2016cites this paper
• Molecular Structure of Aggregated Amyloid-β: Insights from Solid-State Nuclear Magnetic Resonance.

  2016cites this paper
• Intranasal Administration of a Polyethylenimine-Conjugated Scavenger Peptide Reduces Amyloid-β Accumulation in a Mouse Model of Alzheimer’s Disease

  2016cites this paper
• Running title : Flexibility and Solvation of A β Hydrophobic Core

  2016cites this paper
• Identification and characterisation of disulphide bonds in therapeutic proteins by using Raman Spectroscopy

  2016cites this paper
• Amyloid β-Protein Assembly and Alzheimer's Disease: Dodecamers of Aβ42, but Not of Aβ40, Seed Fibril Formation.

  2016cites this paper
• Amyloid-β and amyloid associated proteins in the pathology and diagnosis of Alzheimer's disease

  2016cites this paper
• Structure of amyloid oligomers and their mechanisms of toxicities: Targeting amyloid oligomers using novel therapeutic approaches.

  2016cites this paper
• Expediting the Discovery and Potential Translation of Theranostic Agents for Alzheimer's Disease

  2015cites this paper
• Molecular structure of monomorphic peptide fibrils within a kinetically trapped hydrogel network

  2015cites this paper
• Spectroscopic and Microscopic Studies of Aggregation and Fibrillation of Lysozyme in Water/Ethanol Solutions.

  2015cites this paper
• A kinetic study of ovalbumin fibril formation: the importance of fragmentation and end-joining.

  2015cites this paper
• In-vivo and in-vitro techniques used to investigate Alzheimer's disease

  2015cites this paper
• [Physico-chemical methods for studing β-amyloid aggregation].

  2015cites this paper
• Amyloids: from pathogenesis to function

  2015cites this paper
• Pyroglutamylated Amyloid-β Peptide Reverses Cross β-Sheets by a Prion-Like Mechanism

  2014cites this paper
• Direct Evidence for Self-Propagation of Different Amyloid-β Fibril Conformations

  2014cites this paper
• Therapeutic approaches against common structural features of toxic oligomers shared by multiple amyloidogenic proteins.

  2014cites this paper
• Biophysical Investigations of the Aβ Aggregation Process

  2014cites this paper
• Influence of repeat numbers on self-assembly rates of repetitive recombinant spider silk proteins.

  2014cites this paper
• Physical and structural basis for polymorphism in amyloid fibrils

  2014cites this paper
• Structural Heterogeneity and Bioimaging of S100 Amyloid Assemblies

  2014cites this paper
• Is Supramolecular Filament Chirality the Underlying Cause of Major Morphology Differences in Amyloid Fibrils?

  2014cites this paper
• Neuropathology and biochemistry of Aβ and its aggregates in Alzheimer’s disease

  2014cites this paper
• Monoclonal Antibodies against Aβ42 Fibrils Distinguish Multiple Aggregation State Polymorphisms in Vitro and in Alzheimer Disease Brain*

  2014cites this paper
• Transient dynamics of Aβ contribute to toxicity in Alzheimer’s disease

  2014cites this paper
• Tuning nanostructure dimensions with supramolecular twisting.

  2013cites this paper
• Amyloid Peptide Self-Assembly in Protic Ionic Liquids

  2013cites this paper
• Amyloid-β Protofibrils: Size, Morphology and Synaptotoxicity of an Engineered Mimic

  2013cites this paper
• 1,4-Substituted 4-(1H)-pyridylene-hydrazone-type inhibitors of AChE, BuChE, and amyloid-β aggregation crossing the blood-brain barrier.

  2013cites this paper
• Neurotoxicity of Prion Peptides Mimicking the Central Domain of the Cellular Prion Protein

  2013influential citation
• Mechanism of an ATP-independent Protein Disaggregase

  2013cites this paper
• Synthesis of tetrahydroxybiphenyls and tetrahydroxyterphenyls and their evaluation as amyloid-β aggregation inhibitors.

  2013cites this paper
• Molecular structures of amyloid and prion fibrils: consensus versus controversy.

  2013cites this paper
• Dévelopement d'une méthode bio-informatique pour la prédiction des régions amyloidogéniques dans les protéines.

  2013cites this paper
• Polymorph-specific kinetics and thermodynamics of β-amyloid fibril growth.

  2013cites this paper
• Peptide concentration alters intermediate species in amyloid β fibrillation kinetics.

  2013cites this paper
• Novel mechanistic insight into the molecular basis of amyloid polymorphism and secondary nucleation during amyloid formation.

  2013cites this paper
• Hydrogen bonding involving side chain exchangeable groups stabilizes amyloid quarternary structure.

  2013cites this paper
• Atomic structure and hierarchical assembly of a cross-β amyloid fibril

  2013cites this paper
• Synthesis of d-amino acid peptides and their effect on beta-amyloid aggregation and toxicity in transgenic Caenorhabditis elegans

  2013cites this paper
• Computational assembly of polymorphic amyloid fibrils reveals stable aggregates.

  2013cites this paper
• Specific domains of Aβ facilitate aggregation on and association with lipid bilayers.

  2013cites this paper
• Inhibiting the nucleation of amyloid structure in a huntingtin fragment by targeting α-helix-rich oligomeric intermediates.

  2012cites this paper
• Oligomeric intermediates in amyloid formation: structure determination and mechanisms of toxicity.

  2012cites this paper
• Disulfide Bridges Remain Intact while Native Insulin Converts into Amyloid Fibrils

  2012cites this paper
• Single-particle characterization of Aβ oligomers in solution.

  2012cites this paper
• Antiparallel β-sheet architecture in Iowa-mutant β-amyloid fibrils

  2012cites this paper
• Facile methodology for monitoring amyloid-β fibrillization.

  2012cites this paper
• Kinetically competing huntingtin aggregation pathways control amyloid polymorphism and properties.

  2012cites this paper
• Discovery and Structure Activity Relationship of Small Molecule Inhibitors of Toxic β-Amyloid-42 Fibril Formation*

  2012cites this paper
• Solid-state NMR Reveals a Close Structural Relationship between Amyloid-β Protofibrils and Oligomers*

  2012cites this paper
• Preclinical PET as Translational Tool for Imaging Alzheimer's Disease

  2012cites this paper
• Structure, conformational dynamics and formation of large amyloids: the case of alpha-synuclein fibrils

  2012cites this paper
• Structural polymorphism and possible pathways of amyloid fibril formation on the example of insulin protein

  2012cites this paper
• Methods for Analysis of Amyloid-β Aggregates

  2012cites this paper
• Observation of molecular inhibition and binding structures of amyloid peptides.

  2012cites this paper
• Point Mutations in Aβ Result in the Formation of Distinct Polymorphic Aggregates in the Presence of Lipid Bilayers

  2011cites this paper
• Recent progress in understanding Alzheimer's β-amyloid structures.

  2011cites this paper
• In Sup35p filaments (the [PSI+] prion), the globular C‐terminal domains are widely offset from the amyloid fibril backbone

  2011cites this paper
• Point mutations in Aβ induce polymorphic aggregates at liquid/solid interfaces.

  2011cites this paper
• Studies of the growth, evolution, and self‐aggregation of β‐amyloid fibrils using tapping‐mode atomic force microscopy

  2011cites this paper